General Information of Drug (ID: DM8I5UF)

Drug Name
B-5354a Drug Info
Synonyms B-5354b; B-5354c; Sphingosine kinase inhibitors, Sankyo
Indication
Disease Entry ICD 11 Status REF
Arteriosclerosis BD40 Terminated [1]
Cross-matching ID
PubChem CID
9905128
TTD Drug ID
DM8I5UF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phenoxodiol DMBUJVX Ovarian cancer 2C73 Phase 1/2 [3]
GSK618334 DMJPXZ4 Drug abuse 6C4G.1Z Phase 1 [4]
PMID27539678-Compound-6 DMBKNDE N. A. N. A. Patented [5]
Methylbenzenesulfonamide derivative 1 DMUNME2 N. A. N. A. Patented [5]
PMID27539678-Compound-12 DMNIKTA N. A. N. A. Patented [5]
PMID27539678-Compound-10 DM61SR0 N. A. N. A. Patented [5]
PMID27539678-Compound-16 DMMDJH8 N. A. N. A. Patented [5]
PMID27539678-Compound-14 DMZ02LA N. A. N. A. Patented [5]
PMID27539678-Compound-13 DM1J2V8 N. A. N. A. Patented [5]
PMID27539678-Compound-11 DMIKAJC N. A. N. A. Patented [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sphingosine kinase 1 (SPHK1) TTOHFIY SPHK1_HUMAN Inhibitor [2]

References

1 B-535a, b and c, new sphingosine kinase inhibitors, produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical properties and structure determination. J Antibiot (Tokyo). 2000 Aug;53(8):753-8.
2 Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium. J Antibiot (Tokyo). 2000 Aug;53(8):759-64.
3 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
4 Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Oncotarget. 2016 Dec 6;7(49):80586-80598.
5 Sphingosine kinase inhibitors: a review of patent literature (2006-2015).Expert Opin Ther Pat. 2016 Dec;26(12):1409-1416.